Julen
Oyarzabal Santamarina
Researcher to 2018
Universidad Complutense de Madrid
Madrid, EspañaPublications in collaboration with researchers from Universidad Complutense de Madrid (2)
2021
-
Dual Targeting of G9a and DNA Methyltransferase-1 for the Treatment of Experimental Cholangiocarcinoma
Hepatology, Vol. 73, Núm. 6, pp. 2380-2396
2016
-
Fatty acid amide hydrolase inhibition for the symptomatic relief of Parkinson's disease
Brain, Behavior, and Immunity, Vol. 57, pp. 94-105